1 Biological Drugs Market Overview
1.1 Product Overview and Scope of Biological Drugs
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Sales Growth Rate Comparison by Type (2023-2032)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Biological Drugs Segment by Application
1.3.1 Global Biological Drugs Sales Comparison by Application: (2023-2032)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global Biological Drugs Revenue 2018-2032
1.4.2 Global Biological Drugs Sales 2018-2032
1.4.3 Biological Drugs Market Size by Region: 2018 Versus 2022 Versus 2032
2 Biological Drugs Market Competition by Manufacturers
2.1 Global Biological Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biological Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Biological Drugs Manufacturing Sites, Area Served, Product Type
2.5 Biological Drugs Market Competitive Situation and Trends
2.5.1 Biological Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biological Drugs Players Market Share by Revenue
2.5.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Drugs Retrospective Market Scenario by Region
3.1 Global Biological Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Biological Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Biological Drugs Market Facts & Figures by Country
3.3.1 North America Biological Drugs Sales by Country
3.3.2 North America Biological Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biological Drugs Market Facts & Figures by Country
3.4.1 Europe Biological Drugs Sales by Country
3.4.2 Europe Biological Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biological Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Biological Drugs Sales by Region
3.5.2 Asia Pacific Biological Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biological Drugs Market Facts & Figures by Country
3.6.1 Latin America Biological Drugs Sales by Country
3.6.2 Latin America Biological Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biological Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Biological Drugs Sales by Country
3.7.2 Middle East and Africa Biological Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biological Drugs Historic Market Analysis by Type
4.1 Global Biological Drugs Sales Market Share by Type (2018-2023)
4.2 Global Biological Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Biological Drugs Price by Type (2018-2023)
5 Global Biological Drugs Historic Market Analysis by Application
5.1 Global Biological Drugs Sales Market Share by Application (2018-2023)
5.2 Global Biological Drugs Revenue Market Share by Application (2018-2023)
5.3 Global Biological Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly Biological Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Takeda Biological Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Biological Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Amgen Biological Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Biological Drugs Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Merck Biological Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abbott Laboratories Biological Drugs Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Baxter Biological Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Biological Drugs Description and Business Overview
6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Biological Drugs Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Biological Drugs Description and Business Overview
6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Biogen Biological Drugs Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 GlaxoSmithKline
6.13.1 GlaxoSmithKline Corporation Information
6.13.2 GlaxoSmithKline Biological Drugs Description and Business Overview
6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio
6.13.5 GlaxoSmithKline Recent Developments/Updates
7 Biological Drugs Manufacturing Cost Analysis
7.1 Biological Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biological Drugs
7.4 Biological Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biological Drugs Distributors List
8.3 Biological Drugs Customers
9 Biological Drugs Market Dynamics
9.1 Biological Drugs Industry Trends
9.2 Biological Drugs Market Drivers
9.3 Biological Drugs Market Challenges
9.4 Biological Drugs Market Restraints
10 Global Market Forecast
10.1 Biological Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biological Drugs by Type (2023-2032)
10.1.2 Global Forecasted Revenue of Biological Drugs by Type (2023-2032)
10.2 Biological Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biological Drugs by Application (2023-2032)
10.2.2 Global Forecasted Revenue of Biological Drugs by Application (2023-2032)
10.3 Biological Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biological Drugs by Region (2023-2032)
10.3.2 Global Forecasted Revenue of Biological Drugs by Region (2023-2032)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
